Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
31 - 40 out of 69Page size: 10
  1. 2021
  2. Published

    Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 1, p. 22-31 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: European Heart Journal. 42, 13, p. 1216-1227 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: The simple trial

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2021, In: Journal of the American Heart Association. 10, 15, e020418.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial

    Rossing, Peter, Strand, J., Avogaro, A., Becka, M., Kanefendt, F. & Otto, C., 2021, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 36, 12, p. 2263–2273

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

    Persson, F., Rossing, Peter, Vart, P., Chertow, G. M., Hou, F. F., Jongs, N., McMurray, J. J., Correa-Rotter, R., Bajaj, H. S., Stefansson, B., Toto, R. D., Langkilde, A. M., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2021, In: Diabetes Care. 44, 8, p. 1894-1897 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes

    Stougaard, E. B., Winther, S. A., Amadid, H., Frimodt-Møller, M., Persson, F., Hansen, T. W. & Rossing, Peter, 2021, In: PLoS ONE. 16, e0254859.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy

    Winther, S. A., Mannerla, M. M., Frimodt-Møller, M., Persson, F., Hansen, T. W., Lehto, M., Hörkkö, S., Blaut, M., Forsblom, C., Groop, P. H. & Rossing, Peter, 2021, In: Scientific Reports. 11, 1, 15208.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes

    Filippatos, G. & FIDELIO-DKD Investigators, F. I., 2021, In: Journal of the American College of Cardiology. 78, 2, p. 142-152 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

    FIDELIO-DKD Investigators, F. I., 2021, In: Circulation. 143, 6, p. 540-552 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Genome-Wide Association Study of Circulating Interleukin 6 Levels Identifies Novel Loci

    Ahluwalia, T. S., Prins, B. P., Abdollahi, M., Armstrong, N. J., Aslibekyan, S., Bain, L., Jefferis, B., Baumert, J., Beekman, M., Ben-Shlomo, Y., Bis, J. C., Mitchell, B. D., de Geus, E., Delgado, G. E., Marek, D., Eriksson, J., Kajantie, E., Kanoni, S., Kemp, J. P., Lu, C. & 31 others, Marioni, R. E., McLachlan, S., Milaneschi, Y., Nolte, I. M., Petrelis, A. M., Porcu, E., Sabater-Lleal, M., Naderi, E., Seppälä, I., Shah, T., Singhal, G., Standl, M., Teumer, A., Thalamuthu, A., Thiering, E., Trompet, S., Ballantyne, C. M., Benjamin, E. J., Casas, J. P., Toben, C., Dedoussis, G., Deelen, J., Durda, P., Engmann, J., Feitosa, M. F., Grallert, H., Hammarstedt, A., Jess, T., Rossing, Peter, Sørensen, Thorkild I.A. & CHARGE Inflammation Working Group, C. I. W. G., 2021, In: Human Molecular Genetics. 30, 5, p. 393–409

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 12937790